HMNC Brain Health and Develco Pharma Announce Last Patient Being Randomized in Oral Prolonged-Release Ketamine (KET01) Trial for Treatment-Resistant Depression - Yahoo Finance UK

Submitted by Anonymous (not verified) on Tue, 03/28/2023 - 12:00

HMNC Brain Health and Develco Pharma Announce Last Patient Being Randomized in Oral Prolonged-Release Ketamine (KET01) Trial for Treatment-Resistant Depression Yahoo Finance UK

Log in to post comments